phate-buffered saline (Oxoid; Med-Ox Chemicals) containing 0.005% thimerosal, followed by a final wash in 0.9% NaCl containing 0.005% thimerosal and pelleting at 1,000 x g for 5 min. Erythrocytes of approximately the same age and from the same sheep source were used throughout the study. SpA. Soluble purified staphylococcal protein A (SpA) was purchased from Sigma Chemical Co., St. Louis, Mo. The binding capacity of the product, as given by the manufacturer, was 11.0 mg of human immunoglobulin G (IgG) per mg of solid. A working solution of 0.1 mg of SpA per ml was prepared from a 0.5-mg/ml stock by dilution in 0.5 mg of human serum albumin (Sigma Chemical Co.) per ml to yield a total protein concentration of 0.5 mg/ml.
A single radial hemolysis test, which overcomes many of the problems of conventional complement fixation tests, was developed for the quantitation of virus complement-fixing antibodies. The test procedure utilized staphylococcal protein A-coated sheep erythrocytes immobilized in agarose into which antigen was incorporated. Undiluted heat-inactivated serum samples were allowed to diffuse radially from wells punched in the agarose. Protein A served to concentrate the subsequent antigen-antibody reaction on the surface of the erythrocytes. Zones of hemolysis were developed by flooding with complement. With adenovirus as a model, basic test parameters were defined, and optimum reagent concentrations and diffusion conditions were determined. A positive linear relationship was found to exist between zone diameter and increasing log concentration of specific antiserum. No correlation was found between zone diameter and total concentration of immunoglobulin G in test sera. Sera rendered anticomplementary by the addition of carrageenan produced hemolytic zones equal in diameter to those observed with untreated sera. Seventy-seven human sera with known complement fixation titers were tested by this method. Good correlation (r = 0.74) between the complement fixation test and single radial hemolysis was observed. This test was highly reproducible and more sensitive than the conventional complement fixation test.
Single radial hemolysis (SRH) techniques have been used by numerous investigators for measuring complement fixation (CF) antibodies to a variety of viruses (6, 8, 18-20, 22, 23) . These techniques are based on the radial diffusion of antibody in a gel containing antigen-sensitized erythrocytes and complement; subsequent antigen-antibody reaction in the presence of complement results in circular zones of hemolysis with diameters proportional to the concentration of antibody. For the most part, these procedures are limited to quantitation of antibody to hemagglutinating viruses. SRH techniques previously described for the measurement of antibodies to non-hemagglutinating viruses involved chemical attachment of antigen to erythrocytes, a procedure which requires the use of large volumes of purified or concentrated virus (11) .
Using adenovirus as a model, we have developed a modified SRH test for the quantitation of CF antibody to non-hemagglutinating viruses. It was found to be simple to perform, more sensitive than conventional CF tests, and utilized only small quantities of crude virus antigen. We suggest this technique as a new alternative method for the assay of CF antibody.
MATERIALS AND METHODS
Antigen. Adenovirus CF antigen was purchased from Microbiological Associates, Walkersville, Md. The CF titer of the antigen, as given by the manufacturer, was 1:32. For the SRH test, antigen was diluted 1:8 in veronal-buffered saline (VBS) (Oxoid; Med-Ox Chemicals, Ottawa, Ontario, Canada).
Sera. Clinical specimens of human sera from patients with known or suspected recent infection with adenovirus, including single serum samples and acute-and convalescentphase pairs, were kindly supplied by the Provincial Laboratory of Public Health, University of Alberta, Edmonton, and by Foothills Hospital, University of Calgary, Calgary, Al- 11 .0 mg of human immunoglobulin G (IgG) per mg of solid. A working solution of 0.1 mg of SpA per ml was prepared from a 0.5-mg/ml stock by dilution in 0.5 mg of human serum albumin (Sigma Chemical Co.) per ml to yield a total protein concentration of 0.5 mg/ml.
Agarose. A mixture of 3.0% (wt/vol) SeaPlaque agarose (FMC Corp., Marine Colloids Div., Rockland, Maine) and 0.2% (wt/vol) DEAE-dextran (Pharmacia, Uppsala, Sweden) in VBS was prepared by heating to boiling and cooling to 42°C in a temperature-controlled water bath.
SRH. After a series of experiments in which concentrations of antigen, chromium chloride (CrCl3), SpA, and SRBC, incubation time, and temperature were optimized, the following procedure was adopted for performance of the SRH test. SpA was coupled to SRBC by the CrCl3 technique (7, 13) as follows. One volume of SpA was added to one volume of washed, packed SRBC, and the suspension was mixed on a Vortex apparatus. To this was added six volumes of 0.05 M imidazole buffer (pH 6.6) containng 0.9% NaCl. Ten volumes of 0.375 mM CrCl3 in 0.9% NaCl (pH 5.0) was then added dropwise, with constant mixing during addition. The suspension was held for 30 min at room temperature with occasional mixing, after which the reaction was terminated by the addition of phosphate-buffered saline. The (10) .
Clinical evaluation. Seventy-seven specimens of human sera from patients with known or suspected recent infection with adenovirus were tested by both CF and SRH tests. For the SRH test, each serum was tested undiluted in duplicate on two separate occasions in gels containing adenovirus antigen and in control gels, one series with SRBC-SpA only (no antigen), one series with human serum albumin-activated SRBC only (no SpA, no antigen), and one series with unactivated SRBC only (without CrC13 treatment).
RESULTS
Effect of antigen concentration on diameter of zone of hemolysis. To investigate the relationship between concentration of antigen in the gel and hemolytic zone diameter, dilutions of antisera were tested in gels containing different concentrations of antigen. At each serum dilution examined, the diameter of the hemolytic zone increased with decreasing concentration of antigen in the gel and reached a maximum at an antigen dilution of 1:8. At antigen dilutions greater than 1:8, the zone diameter decreased, as did the Relationship between diameter of zone of hemolysis and dilution of antiserum. The relationship between antiserum dilution (antibody concentration) and hemolytic zone diameter was investigated by testing dilutions of three sera, each with a different initial antibody content, and plotting hemolytic zone diameter as a function of antiserum dilution ( Fig.  2A) . Plotting of the reciprocal log2 dilution of the same sera against hemolytic zone diameter produced straight lines, with slopes approximately equal and correlation coefficients close to 1 (Fig. 2B) . To determine the acceptable limits of error of the SRH technique, 95% confidence interval bands were constructed around the regression lines in Fig. 2B . Increases in hemolytic zone diameters which fell outside of these error bounds were considered significant. By this method, the maximum error boundary was determined to be ±0.3 mm. Thus, a difference in diameter of 0.7 mm between two serum samples after 18 h of diffusion at 26°C gave a probability of 0.95 for a positive difference in antibody concentration.
Effect of diffusion time and temperature on diameter of zone of hemolysis. The effect of temperature on the rate of serum diffusion and the kinetics of development of hemolytic zones with time were investigated by allowing serum to diffuse at three different temperatures and adding complement at various times after serum application. The relationship between the diameter of the zone of hemolysis and reciprocal log2 serum dilution was linear at all reaction temperatures and diffusion times (Fig. 3) . With increasing time periods of diffusion, the slope of the regression lines increased, thus indicating that sensitivity in distinguishing between sera of different antibody concentrations increased with prolonged diffusion. The intercept of the regression lines also increased with increasing periods of diffusion, indicating a higher overall sensitivity with increasing diffusion time. As expected, the rate of diffusion was temperature dependent, with more rapid diffusion occurring at the higher temperatures. Some SRBC degeneration had occurred by 48 h of diffusion at 4 and 26°C, and zone borders were faint and diffuse, making quantitation difficult; at 37°C, extensive lysis of SRBC had occurred. For practical reasons, a diffusion time of 18 h at 26°C was considered optimum.
Reproducibility. Three levels of variation were examined: that occurring within a gel, that between gels prepared at the same time, and that occurring between gels prepared on different days. The first two levels of variation were investigated simultaneously. A 1:8 dilution of reference antiserum (CF titer, 1:64) was tested in 10 replicates in each of four gels. To provide an influence of the position of the wells within a gel, measurements were grouped in blocks of five corresponding to five contiguous areas of a single gel, each block containing two wells. Two-way analysis of variance of the data obtained indicated that variation from gel to gel exceeded that occurring within gels but that neither variation was significant at the 1% level (Fol). The combined variance within and between gels was minimal and not significant at either the 1 or 5% levels (FOl, F05). Day-to-day reproducibility was examined by performing replicate SRH experiments on 2 separate days. By using the same reagent stock solutions but fresh working solutions of reagents and fresh serum dilutions on each day, twofold dilutions of a reference antiserum (CF titer, 1:32) were tested in four replicates. One-way analysis of variance performed on the measurements obtained each day at each dilution indicated that there was no significant variance in the diameters at any of the dilutions (Fol). tions of anticomplementary substances in antisera had any effect on hemolytic zone diameter, two antisera were made anticomplementary and titrated by both conventional CF test and SRH (Fig. 4) . Although treated antisera exhibited anticomplementary activity in the CF test to a titer of 1:1,024 and 1:2,048, respectively, the same sera were not anticomplementary when tested by SRH. Relationship between diameter of zone of hemolysis and concentration of IgG. To determine whether the concentration of IgG in sera affected the diameter of the hemolytic zone, the IgG content of a battery of sera was determined, and the values obtained were plotted as a function of zone diameter by SRH. A regression line with slope of zero and correlation coefficient of zero was generated from the data points (Fig. 5) Relationship between diameter of zone of hemolysis and CF titer. Good correlation (r = 0.74) was observed between the diameter of the zone of hemolysis by SRH and antibody titer by the conventional CF test (Fig. 6) . No zones of hemolysis were noted in any of the control gels. Specificity and sensitivity. A comparison of CF and SRH test results obtained from 92 sera revealed that 52 were positive and 32 were negative by both tests (91% agreement). Although none of the sera which were positive by the CF test were positive by SRH, eight which were negative in the CF test were negative by SRH. Since the lower limit of sensitivity of the CF test is by convention 1:8, sera initially were not tested at dilutions <1:8. That low levels of antibody were indeed present but undetected in some of these sera was confirmed by the finding that five of the eight sera which were negative at a dilution of 1:8 in the CF test were actually positive by CF when tested at dilutions <1:8. Thus, when the CF test was performed at dilutions -1:2, 57 sera were positive and 32 were negative by both SRH and CF test (97% agreement). In addition, the eight sera which were positive by SRH, but negative by CF test at a dilution of 1:8, produced zones of hemolysis with diameters which were correspondingly smaller than those produced by sera with CF titers of .1:8. These findings would suggest that the sensitivity of the SRH test was greater than that of the CF test.
Detection of seroconversions. Acute-and convalescentphase sera with known CF titers were available from seven patients. In all cases, the difference in hemolytic zone diameter by SRH between acute and convalescent serum pairs was greater than 0.7 mm (Table 1) . On the basis of the limits of error for the test, all seroconversions were therefore considered to be significant. By contrast, one of the sera exhibited only a twofold increase in antibody titer by the CF test, a difference which, in this test, is not considered significant. Because of the nature of the dilution series (twofold) utilized in the CF test, by convention a minimum fourfold (400%) increase in antibody concentration between acute and convalescent serum samples is required for significance in this test. A 400% increase in antibody concentration corresponded to an increase in hemolytic zone diameter of ca. 2.8 mm (Fig. 2B ). From this relationship it was calculated that an increase in zone diameter of 0.7 mm, necessary to prove significance in the SRH test, required only a singlefold (100%) increase in antibody concentration. DISCUSSION The characteristic biological property of SpA is its ability to bind to the F, portion of subclasses 1, 2, and 4 of human IgG; one molecule of SpA can bind two molecules of IgG (5, 21) . In the SRH model described in this paper, SpA serves to concentrate antigen-antibody complexes on the surface of SRBC. A diagramatic representation of the proposed mechanism is presented (Fig. 7) .
Variation in the extent of lysis in hemolytic zones was (12) but is not consistent with the models described by Pereira et al. (17) and Mancini et al. (16) , who found that the slope of the regression lines relating zone area and the concentration of reactant in the well varied inversely with the concentration of reactant in the gel.
The diameter of the zone of hemolysis varied directly with the dilution of specific antiserum in the well, thus suggesting a proportional relationship between zone diameter and specific antibody concentration. This relationship similarly exists in SRH systems for hemagglutinating viruses (1, 8, 9, 18, 19, 23) . As previously reported by others (9, 19, 20) (2) . Although several procedures are used for the removal of these substances in sera, none has gained universal acceptance, since most can result in altered antibody titers. The SRH test described in this paper, therefore, offers an obvious advantage to the conventional CF test by virtue of the fact that problems associated with the presence of anticomplementary substances in sera are avoided.
Results obtained by SRH correlated well with those obtained by the CF test. Although a considerable degree of variability in zone diameter was present among sera with the same CF titer, this may be accounted for by a lack of precision inherent in the CF test, rather than by imprecision in the SRH test. Theoretically, the SRH test would be expected to give a more precise quantitation of antibody than would the CF test. The former method measures the absolute content of antibody in an undiluted sample, whereas the latter method is semiquantitative, and antibody concentration is estimated by dilution endpoint.
The sensitivity of the SRH test was found to be greater than that of the CF test. Whereas the lower limit of sensitivity of the CF test is by convention 1:8, sera with CF titers of <1:8 produced measureable zones of hemolysis by SRH. In the CF test, quantitation of antibodies is based on serial serum dilutions and endpoint determinations, and because of the magnitude of error inherent in these procedures, only fourfold (400%) increases in antibody titer can be considered significant. In the modified SRH, sera were tested undiluted, and an increase in zone diameter of 0.7 mm, which corresponded to a singlefold (100%) increase in antibody concentration, was significant.
Using adenovirus as a model, we have developed a modified SRH technique for the quantitation of CF antibodies to non-hemagglutinating viruses. Theoretically, this method could be used to quantitate CF antibody to any virus, whether hemagglutinating or non-hemagglutinating. 
